Annual CFF
-$3.38 M
-$137.35 M-102.52%
31 December 2023
Summary:
Axonics annual cash flow from financing activities is currently -$3.38 million, with the most recent change of -$137.35 million (-102.52%) on 31 December 2023. During the last 3 years, it has fallen by -$147.57 million (-102.34%).AXNX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$2.52 M
+$2.28 M+947.72%
30 September 2024
Summary:
Axonics quarterly cash flow from financing activities is currently $2.52 million, with the most recent change of +$2.28 million (+947.72%) on 30 September 2024. Over the past year, it has increased by +$1.65 million (+187.59%).AXNX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$3.59 M
+$1.65 M+84.68%
30 September 2024
Summary:
Axonics TTM cash flow from financing activities is currently $3.59 million, with the most recent change of +$1.65 million (+84.68%) on 30 September 2024. Over the past year, it has increased by +$7.39 million (+194.60%).AXNX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AXNX Cash From Financing Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -102.5% | +187.6% | +194.6% |
3 y3 years | -102.3% | +65.8% | -97.9% |
5 y5 years | -102.0% | +2174.8% | -97.4% |
AXNX Cash From Financing High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | ||||||
5 y | 5 years | ||||||
alltime | all time | -102.0% | -98.2% | -98.6% |
Axonics Cash From Financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $2.52 M(+947.7%) | $3.59 M(+84.7%) |
June 2024 | - | $241.00 K(-2.8%) | $1.95 M(-138.4%) |
Mar 2024 | - | $248.00 K(-57.1%) | -$5.06 M(+49.8%) |
Dec 2023 | -$3.38 M(-102.5%) | $578.00 K(-34.2%) | -$3.38 M(-11.0%) |
Sept 2023 | - | $878.00 K(-113.0%) | -$3.80 M(-103.0%) |
June 2023 | - | -$6.77 M(-450.6%) | $127.21 M(-5.4%) |
Mar 2023 | - | $1.93 M(+1098.8%) | $134.45 M(+0.4%) |
Dec 2022 | $133.97 M(-21.4%) | $161.00 K(-99.9%) | $133.97 M(-0.0%) |
Sept 2022 | - | $131.88 M(>+9900.0%) | $134.01 M(+3572.5%) |
June 2022 | - | $480.00 K(-66.8%) | $3.65 M(-96.8%) |
Mar 2022 | - | $1.44 M(+614.9%) | $115.74 M(-32.1%) |
Dec 2021 | $170.51 M | $202.00 K(-86.7%) | $170.51 M(-0.5%) |
Sept 2021 | - | $1.52 M(-98.6%) | $171.37 M(+0.1%) |
June 2021 | - | $112.57 M(+100.3%) | $171.14 M(-14.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2021 | - | $56.22 M(+5228.4%) | $200.06 M(+38.7%) |
Dec 2020 | $144.19 M(+30.0%) | $1.05 M(-18.6%) | $144.19 M(-43.1%) |
Sept 2020 | - | $1.30 M(-99.1%) | $253.63 M(+0.5%) |
June 2020 | - | $141.50 M(>+9900.0%) | $252.44 M(+126.9%) |
Mar 2020 | - | $344.00 K(-99.7%) | $111.25 M(+0.3%) |
Dec 2019 | $110.95 M(-32.9%) | $110.49 M(>+9900.0%) | $110.95 M(-18.4%) |
Sept 2019 | - | $111.00 K(-64.0%) | $136.04 M(+0.1%) |
June 2019 | - | $308.00 K(+600.0%) | $135.94 M(+0.2%) |
Mar 2019 | - | $44.00 K(-100.0%) | $135.63 M(-18.0%) |
Dec 2018 | $165.34 M(+374.9%) | $135.58 M(>+9900.0%) | $165.34 M(+455.5%) |
Sept 2018 | - | $6000.00(>+9900.0%) | $29.76 M(+0.0%) |
June 2018 | - | $0.00(-100.0%) | $29.76 M(0.0%) |
Mar 2018 | - | $29.76 M | $29.76 M |
Dec 2017 | $34.81 M(+2042.5%) | - | - |
Dec 2016 | $1.63 M | - | - |
FAQ
- What is Axonics annual cash flow from financing activities?
- What is the all time high annual CFF for Axonics?
- What is Axonics annual CFF year-on-year change?
- What is Axonics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Axonics?
- What is Axonics quarterly CFF year-on-year change?
- What is Axonics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Axonics?
- What is Axonics TTM CFF year-on-year change?
What is Axonics annual cash flow from financing activities?
The current annual CFF of AXNX is -$3.38 M
What is the all time high annual CFF for Axonics?
Axonics all-time high annual cash flow from financing activities is $170.51 M
What is Axonics annual CFF year-on-year change?
Over the past year, AXNX annual cash flow from financing activities has changed by -$137.35 M (-102.52%)
What is Axonics quarterly cash flow from financing activities?
The current quarterly CFF of AXNX is $2.52 M
What is the all time high quarterly CFF for Axonics?
Axonics all-time high quarterly cash flow from financing activities is $141.50 M
What is Axonics quarterly CFF year-on-year change?
Over the past year, AXNX quarterly cash flow from financing activities has changed by +$1.65 M (+187.59%)
What is Axonics TTM cash flow from financing activities?
The current TTM CFF of AXNX is $3.59 M
What is the all time high TTM CFF for Axonics?
Axonics all-time high TTM cash flow from financing activities is $253.63 M
What is Axonics TTM CFF year-on-year change?
Over the past year, AXNX TTM cash flow from financing activities has changed by +$7.39 M (+194.60%)